Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (October 2020)
18 slides from Coloplast A/s Class B's investor day presentation, Oct 9, 2020
Slide 1: Sustainable growth leadership
Sustainability Sustainable growth leadership Coloplast Capital Markets Day 2020 Virtual break-out session October 9th 2020 Camilla Hjort Pagh, SVP Global Quality & Regulatory Affairs Christoffer Quist Weesgaard, Senior Sustainability Manager Making life easier
Slide 2: Supporting sustainable development with a strong emphasis on improving our environmental performance
Supporting sustainable development with a strong emphasis on improving our environmental performance Our mission Making life easier for people with intimate healthcare needs Our 2025 priority Our 2025 priority Reducing Improving emissions products and packaging 0 emissions from scope 1&2 80% packagi
Slide 3: Our starting point is solid with room to improve
Our starting point is solid with room to improve We have been through a rigorous process to … Supported by our materiality assessment, access our Sustainability performance ... we have based our priorities on our impacts • Bottom-up assessment based on 23 parameters Governance • Involvement of stake
Slide 4: Coloplast's position on plastic
Coloplast’s position on plastic Plastic is used every day for many things. What happens after plastic is thrown away is causing a problem for our planet. As a manufacturer of medical products made of plastic, Coloplast has a responsibility. We embrace that responsibility and have clear priorities: 1
Slide 5: We are investing up to 250m DKK over the next years to support sustainable environmental development
We are investing up to 250m DKK over the next 5 years to support sustainable environmental development1 Key Sustainability Targets 2025 Scope 1+2 emissions2 Renewable energy Company cars are Reduce business travel electrical Reducing emissions 100% while being a growth company 67% 50% 7% 0% 2% -10%
Slide 6: We continue our strong commitment to responsible operations
We continue our strong commitment to responsible operations Key Sustainability Targets 2025 100% 2.0 Responsible White-collars trained in operations Code of Conduct Loss-time injury rate* is our core values 30% 75% Female representation of teams (Director and above) at VP+ levels meet diverse team t
Slide 7: We have strengthened our governance of Sustainability
We have strengthened our governance of Sustainability Remuneration and Nomination Committee Board of Directors Consists of three members appointed among the Consists of six shareholder-elected and three employee- Board of Directors. elected members. Audit Committee Consists of four members appointed
Slide 8: ESG Appendix
ESG Appendix
Slide 9: Integrating sustainability throughout our raw material flow
Environment: Improving products and packaging Integrating sustainability throughout our raw material flow Raw materials Production Disposal Landfill, incineration or nature 2020 Total: 40,000t (25,000t plastic) • of which 25% is renewable materials* Waste recycled: 36% 75% of packaging is recyclable
Slide 10: We are committed to reducing emissions while growing 7-9% organically
Environment: Reducing emissions We are committed to reducing emissions while growing 7-9% organically 2025 target 2025 target 0 100% 6% Emissions from scope Renewable energy 7% 1 +2 13% 2025 target Our greenhouse 2025 target 5% gas emissions in 56% • Reductions dependent on how much Limit on goods 1
Slide 11: Our mission inherently strives for better outcomes as well as better access to healthcare
Social: Responsible Operations Our mission inherently strives for better outcomes as well as better access to healthcare Raising standards of care Enabling better outcomes Our partnership programme, Access to Healthcare, seeks to improve conditions within ostomy, continence and wound care. Establish
Slide 12: We have initiated a very ambitious Clinical Performance Program
Social: Responsible Operations We have initiated a very ambitious Clinical Performance Program to tackle the biggest issues users face Users are challenged by skin irritation and urinary tract We have made progress on key technologies and infections run clinical trials 91% Intermittent catheter user
Slide 13: We have a strong outset on organisational health that we strive to maintain
Social: Responsible Operations We have a strong outset on organisational health that we strive to maintain Status Ambition Ensuring safety at work 7.9 out of 10 Continued Employee Engagement above industry employee engagement score benchmark* Reducing injuries • 33% reduction in injury rates since 1
Slide 14: Building a culture of inclusion and diversity
Social: Responsible Operations Building a culture of inclusion and diversity Today 2025 ambition 24% YEAR ON YEAR 30% IMPROVEMENT Gender diversity Female representation Female representation at VP+ levels at VP+ levels 51% 75% YEAR ON YEAR IMPROVEMENT Team diversity A team consisting of a max. 75% o
Slide 15: Business with uncompromising integrity is sustainable business
Social: Responsible Operations Business with uncompromising integrity is sustainable business Our way Building a culture of integrity Internal structures supporting integrity BUSINESS ETHICS TRAINING • Business Ethics Management Coloplast business is founded on of white collars: and Audit Framework
Slide 16: Executive compensation is directly correlated with shareholder value creation
Governance Executive compensation is directly correlated with shareholder value creation Short-Term Incentive: Annual Incentive Program Long-Term Incentive: 3-year Rolling Plan ▪ Annual cash bonus of up to 25% of fixed pay ▪ Eligibility once a year to receive stock options with a value at the time o
Slide 17: Board of Directors
Governance Board of Directors Independent? Audit Committee* Committee Nationality Rem. and Nom. YoB BoD since Name Board competencies Other Board positions (selected) Lars Rasmussen ’59 DK No ‘18 X X Extensive executive management and board experience from international listed companies in H. Lundbe
Slide 18: Our mission
Our mission Making life easier for people with intimate healthcare needs Our values Closeness... to better understand Passion... to make a difference Respect and responsibility... to quide us Our vision Setting the global standard for listening and responding Coloplast Group - Ostomy Care / Continen